Navigation Links
Trials begin on potent new hepatitis C drug
Date:5/14/2010

The first clinical trials have started on a new investigational drug, discovered by researchers at Cardiff University, which is being developed to treat infections caused by Hepatitis C virus.

Approximately 170 million people worldwide are affected with Hepatitis C, which can lead to liver cancer, cirrhosis and death. It is the leading cause of liver transplantation in western countries. The current treatment involves two drugs ribavirin and interferon, which has to be given as an injection. Side effects are often severe and lead to patients failing to complete the treatment.

The new drug, INX-189, is taken orally and was first prepared at the Welsh School of Pharmacy in November 2008. Laboratory tests showed it killed 90 per cent of the virus at very low (nanomolar) concentration, making it one of the most potent compounds of its kind developed to date.

US pharmaceutical company Inhibitex, which owns the licence to INX-189 and has been working with the Cardiff team, has now started trials in healthy volunteers to assess the compound's safety. A second trial, which would evaluate the compound's effectiveness on Hepatitis patients, may follow later this year.

Professor Chris McGuigan of the Welsh School of Pharmacy, academic lead on the project, said: "This is still a very early stage of the trials process. However, progress has been encouraging so far, going from the laboratory to human trials within 18 months. We believe that INX-189 offers the possibility of more potency against Hepatitis, more rapid action in the liver, and fewer side effects than existing treatments."


'/>"/>

Contact: Professor Chris McGuigan
McGuigan@Cardiff.ac.uk
44-292-087-4537
Cardiff University
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants
2. Accumed Research Associates Expands Capabilities In Phase I and Bioequivalence Clinical Trials
3. Scott & White Healthcare clinical trials target lymphoma, leukemia
4. Almac's North Carolina Facility Continues Growth in Academically Based Clinical Trials
5. MedTrials Launches New Online Training Website: http://core.medtrials.com
6. Experts Urge Fixes for Clinical Trials System in Crisis
7. SWOG cancer trials network awarded over $120 million in NCI grants
8. Almac to Improve Label Approval Process in Clinical Trials
9. Childhood cancer patients enrolled in clinical trials need clearer communication about their role
10. Medical schools partner to tackle barriers to minority participation in cancer clinical trials
11. Abbreviated Trials Yield Misleading Results: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 17, 2013 The distribution of white ... brain injury (MTBI) closely resembles that found in early ... in the journal Radiology. , “Findings of MTBI ... Alzheimer’s dementia,” said the study’s lead author, Saeed Fakhran, ... Neuroradiology at the University of Pittsburgh School of Medicine. ...
(Date:6/17/2013)... Essential tremor (ET) is the most common ... people in the United States, and millions more worldwide. ... causes ET, there are no medications specifically designed to ... Tremor© is the International Essential Tremor Foundation’s annual research ... cure for this life-altering neurological condition. , “Although millions ...
(Date:6/17/2013)... The distribution of white matter brain abnormalities in ... resembles that found in early Alzheimer,s dementia, according to ... Radiology . , "Findings of MTBI bear a ... said the study,s lead author, Saeed Fakhran, M.D., assistant ... the University of Pittsburgh School of Medicine. "Additional research ...
(Date:6/17/2013)... 17, 2013 Daimer Industries, Inc.®, a ... equipment , such as expertly designed carpet steam cleaner ... Pro Plus 200S for apartment dwellers and homeowners. The ... in 15 minutes and pressure levels up to 75 ... can be used to clean carpet spots and areas ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Nearly 26 ... as many as 79 million adults are estimated to ... to prevent type 2 diabetes through weight loss and ... can help bring your blood sugar level back within ... and factors, 101 Medical Weight Loss physicians can help ...
Breaking Medicine News(10 mins):Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4
... (WASHINGTON, July 1, 2010) Older patients with Hodgkin ... high risk of hospitalization for cardiac complications after completing treatment, ... the journal of the American Society of Hematology. HL is ... and approximately 8,500 people were diagnosed with the disease in ...
... of online information about the most common sports medicine diagnoses ... 2010 issue of the Journal of Bone and Joint ... help make medical decisions need to know that the web ... that we decided to undertake this study is that patients ...
... , ... Living Website known for their guides to green living have launched their most recent guides ... , ... Growandmake.com the online Guide to Sustainable Living has just released four new lifestyle guides to ...
... ... line of pure, certified organic essential oils. , ... Fargo, ND (Vocus) July 1, 2010-- Aromatherapy isn’t new to the field ... for multiple reasons. From the Greeks to the Romans to modern day, essential oils have ...
... ... to Conventional Medical Treatments. , ... Boca Raton, FL (PRWEB) July 2, 2010 -- Amy, a 55 year-old ... traditional drug treatment, which included five daily pills and injections, Amy,s condition only worsened, ...
... ... clients and brokers on June 23- 24, 2010 near the home office in Irving, Texas. ... National Healthcare Reform and Trends.” The topics covered developments in healthcare reform and factors influencing ... (PRWEB) July ...
Cached Medicine News:Health News:Lymphoma patients with cardiovascular disease have increased risk of cardiac hospitalization 2Health News:Consulting 'Dr. Google' 2Health News:Consulting 'Dr. Google' 3Health News:Growandmake.com Launches New Sustainable Living Guides 2Health News:Certified Organic Aromatherapy Oils Available from Swanson Health Products 2Health News:New Approach to Rheumatoid Arthritis 2Health News:New Approach to Rheumatoid Arthritis 3Health News:HealthSmart Hosts First Forum on National Healthcare Reform and Trends 2
(Date:6/17/2013)... June 17, 2013 Breezy , ... their first product this week using a platform technology enabling ... combats halitosis (bad breath) is being sold in major Israeli ... This commercial launch in Israel follows ... and Spain earlier this year, with ...
(Date:6/17/2013)... N.J. , June 17, 2013 ... announced today a definitive agreement to acquire Aragon ... company focused on drugs to treat hormonally-driven cancers. ... receptor antagonist program.  Aragon,s lead product candidate is ... in Phase 2 development for castration resistant prostate ...
(Date:6/17/2013)... Calif. , June 17, 2013  Imprimis ... announced it has completed the acquisition of intellectual ... from the compounding pharmacy operations of ... allows Imprimis to pursue the commercial development of ... a right of first refusal on additional Buderer ...
Breaking Medicine Technology:A Big "LIKE" for Oral Hygiene 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 3Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 2Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 3Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 4Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 5
... 26, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... medical devices worldwide, today announced that it will report its ... after the U.S. market closes on May 9, 2011. Mindray,s ... on May 10, 2011 U.S. Eastern Time (8:00 PM on ...
... 2011 Protect Pharmaceutical Corporation (OTCBB: PRTT) today announced ... Officer Ramesha Sesha as its Chief Executive Officer and ... Protect as the Chief Operating Officer and Board Member ... Nectid Inc where he was the Founder and CEO. ...
Cached Medicine Technology:Mindray to Report First Quarter 2011 Financial Results on May 9, 2011 2Protect Pharmaceutical Corporation Appoints Chief Executive Officer and Chief Financial Officer 2
... by Dr. Earl Crouch ... for corneal and scleral ... to rest on the ... cornea. Easily removed with ...
Accommodates either eye. Slotted, malleable aluminum surface. Correct size holes produce ideal pin hole effect. Packaged 50 per box....
Includes one aluminum Fox eye shield and one eye Garter shield cover. Packaged 50 per box. White only....
Child size. Clear plastic. Accommodates either eye. Packaged 12 per box. Available in either adult or pediatric size....
Medicine Products: